Adult patient diagnosed with NADSYN1 associated congenital NAD deficiency and analysis of NAD levels to be published in: European Journal of Medical Genetics-Reference-Cited by-同舟云学术

Adult patient diagnosed with NADSYN1 associated congenital NAD deficiency and analysis of NAD levels to be published in: European Journal of Medical Genetics

Published:2023-03 Issue:3 Volume:66 Page:104698
ISSN:1769-7212
Container-title:European Journal of Medical Genetics
language:en
Short-container-title:European Journal of Medical Genetics

Author:

Erbs Emilie^ORCID,Brasen Claus Lohman,Lund Allan Meldgaard,Rasmussen Maria

Publisher

Elsevier BV

Subject

Genetics (clinical),Genetics,General Medicine

Reference24 articles.

1. Identification of clinically actionable variants from genome sequencing of families with congenital heart disease;Alankarage;Genet. Med.,2019

2. Luteolinidin protects the postischemic heart through CD38 inhibition with preservation of NAD(P)(H);Boslett;J. Pharmacol. Exp. Therapeut.,2017

3. Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase;Christensen;J. Inherit. Metab. Dis.,2007

4. Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases;Chuenchor;Nat. Commun.,2020

5. Glutamine versus ammonia utilization in the NAD synthetase family;de Ingeniis;PLoS One,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supplementation with NAD+ and its precursors: A rescue of female reproductive diseases;Biochemistry and Biophysics Reports;2024-07

2. Advances in human glutamine-hydrolyzing synthetases and their therapeutic potential;Frontiers in Chemical Biology;2024-06-06

3. A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder;Journal of Clinical Investigation;2024-02-15

4. Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives;International Journal of Molecular Sciences;2024-02-08

5. Metabolic Alterations in NADSYN1-Deficient Cells;Metabolites;2023-12-12